EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License Agreement • February 14th, 2012 • Atossa Genetics Inc • Surgical & medical instruments & apparatus • Washington
This Exclusive Patent License Agreement is made as of July 27, 2009 (“Effective Date”) between Ensisheim Partners, LLC, a Washington limited liability company (“Licensor”), and Atossa Genetics, Inc., a Delaware corporation (“Atossa”). The parties agree as follows:
BUSINESS CONSULTANT AGREEMENTBusiness Consultant Agreement • February 14th, 2012 • Atossa Genetics Inc • Surgical & medical instruments & apparatus
This agreement will begin the effective date of this agreement and will end December 31, 2011. Either party may cancel this agreement on 30 days notice to the other party in writing, by certified mail or personal delivery. This agreement can be extended on an annual basis upon mutual written agreement of the parties.
SUBLEASE AGREEMENTSublease Agreement • February 14th, 2012 • Atossa Genetics Inc • Surgical & medical instruments & apparatus • Washington
This Sublease Agreement (this "Sublease") is made effective as of September 29, 2010, by and between CompleGen, Inc. ("Tenant"), and Atossa Genetics, Inc. ("Subtenant"). The Tenant has previously entered into a lease agreement with Alexandria Real Estate Equities, Inc. (the "Landlord"), said lease agreement dated June 26, 2006 (the "Prime Lease") with a First amendment dated October 1, 2009, which is incorporated by reference and has been provided to Subtenant. Tenant now desires to sublet the leased property to the Subtenant and the Subtenant desires to sublet the leased property from the Tenant. Therefore, the parties agree as follows:
Atossa Genetics Proposal for CFO Services Prepared for Atossa Genetics For Internal Use Only May 28, 2010 Proposal Valid for 30 DaysCfo Services Agreement • February 14th, 2012 • Atossa Genetics Inc • Surgical & medical instruments & apparatus
This is an Agreement (“Agreement”) made as of June 3, 2010, by and between Atossa Genetics, Inc.(also referred to herein as, “Atossa Genetics,” “client,” or “customer”) and Chris Benjamin, (also referred to herein as “consultant,” “CFO” or “Chris Benjamin”) individually referred to as a “party” and collectively referred to herein as the “parties.” This Agreement shall take the place of any and all other agreements that may have been agreed to in verbal, or written, form between the parties.
